Skip to content

CROI: Low rates of resistance seen in Staccato trial of CD4-guided treatment interruptions

CROI: Saquinavir-based combination prevents mother-to-child HIV transmission

Prevalence of UK HIV drug resistance in antiretroviral-naive falls to 9%

ICAAC: Nevirapine still present in breastmilk two weeks after last dose

Primary drug resistance has limited effect on disease progression and response to treatment

Many people with drug-resistant HIV having unprotected sex

TMC125 is safe and effective in patients with NNRTI resistance

UK HIV patients have high levels of primary drug resistance

Tipranavir receives European marketing approval